172 related articles for article (PubMed ID: 38150085)
1. USP10 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells.
Hou S; Zhao T; Deng B; Li C; Li W; Huang H; Hang Q
Med Oncol; 2023 Dec; 41(1):33. PubMed ID: 38150085
[TBL] [Abstract][Full Text] [Related]
2. Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability.
Ma ZQ; Feng YT; Guo K; Liu D; Shao CJ; Pan MH; Zhang YM; Zhang YX; Lu D; Huang D; Zhang F; Wang JL; Yang B; Han J; Yan XL; Hu Y
Mil Med Res; 2022 Sep; 9(1):54. PubMed ID: 36163081
[TBL] [Abstract][Full Text] [Related]
3. Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma.
Miao Y; Wang X; Lai Y; Huang Y; Yin H; Meng X; Liu H; Hou R; Lin W; Zhang X; Zhang X; Chai BC; Zhang F; Guo L; Yang S
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37264968
[TBL] [Abstract][Full Text] [Related]
4. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.
Cao YF; Xie L; Tong BB; Chu MY; Shi WQ; Li X; He JZ; Wang SH; Wu ZY; Deng DX; Zheng YQ; Li ZM; Xu XE; Liao LD; Cheng YW; Li LY; Xu LY; Li EM
Cell Death Differ; 2023 Feb; 30(2):527-543. PubMed ID: 36526897
[TBL] [Abstract][Full Text] [Related]
5. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
[TBL] [Abstract][Full Text] [Related]
6. Role of Integrin β1 in the progression and chemo-resistance of esophageal squamous cell carcinoma.
Xie YH; Ran LQ; Wu ZY; Sun C; Xu XE; Zou HY; Fang WK; Xie JJ
J Cancer; 2022; 13(7):2074-2085. PubMed ID: 35517416
[No Abstract] [Full Text] [Related]
7. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
9. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
Lin WC; Chen LH; Hsieh YC; Yang PW; Lai LC; Chuang EY; Lee JM; Tsai MH
Carcinogenesis; 2019 Jul; 40(7):883-892. PubMed ID: 30576425
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling.
Li P; Yang L; Park SY; Liu F; Li AH; Zhu Y; Sui H; Gao F; Li L; Ye L; Zou Y; Tian Z; Zhao Y; Costa M; Sun H; Zhao X
Oncogene; 2024 Mar; 43(12):899-917. PubMed ID: 38317006
[TBL] [Abstract][Full Text] [Related]
11. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
13. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
14. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
15. Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.
Li LY; Jiang H; Xie YM; Liao LD; Cao HH; Xu XE; Chen B; Zeng FM; Zhang YL; Du ZP; Chen H; Huang W; Jia W; Zheng W; Xie JJ; Li EM; Xu LY
Oncotarget; 2015 Jun; 6(18):15940-52. PubMed ID: 25909284
[TBL] [Abstract][Full Text] [Related]
16. The DMRTA1-SOX2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma.
Zhang R; Zhou P; Ou X; Zhao P; Guo X; Xi M; Qing C
Oncol Res; 2023; 31(6):887-897. PubMed ID: 37744275
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
[TBL] [Abstract][Full Text] [Related]
18. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
19. CircGOT1 promotes cell proliferation, mobility, and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer.
Zhou S; Guo Z; Lv X; Zhang X
Cell Cycle; 2022 Feb; 21(3):247-260. PubMed ID: 34919012
[TBL] [Abstract][Full Text] [Related]
20. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
